Table 1.

Demographics for patients randomized to 5.0 g/day SRT501 and placebo

SRT501 (N = 6)Placebo (N = 3)
Age, y68.5 ± 10.864.3 ± 6.35
Gender
 Male51
 Female12
Body mass index28.10 ± 4.3526.87 ± 1.61
Race, Caucasian100%100%
Days on study13.3 ± 1.0314.0 ± 0.00
Cumulative dose per subject, g66.7 ± 5.1670.0 ± 0.00